A case report of a recurrence of Mooren's ulcer after cataract surgery;Récurrence d'un ulcère de Mooren après une chirurgie de la cataracte

Journal Francais d'Ophtalmologie

Volumn 30, Issue 3, 2007, Pages

  Schweitzer, C ^a   Touboul, D ^a   Ghiringhelli, C ^b   Colin, J ^a  

^a HÔPITAL PELLEGRIN   (France)

^b HÔPITAL SAINT ANDRÉ   (France)

Author keywords

Autoimmunity; Cyclophosphamide; Cyclosporin; Limbic ulcer; Mooren's ulcer

Indexed keywords

AUTOANTIGEN; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; PROTEIN S 100; S100A12 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ARTICLE; AUTOIMMUNE DISEASE; CASE REPORT; CONJUNCTIVA; CONJUNCTIVITIS; CORNEA; CORNEA TRANSPLANTATION; CORNEA ULCER; FEMALE; HUMAN; IMMUNOLOGY; MIDDLE AGED; MOLECULAR MIMICRY; MULTIMODALITY CANCER THERAPY; NEUTROPHIL; PHACOEMULSIFICATION; POSTOPERATIVE COMPLICATION; RECURRENT DISEASE; VISUAL ACUITY;

AUTOANTIGENS; AUTOIMMUNE DISEASES; COMBINED MODALITY THERAPY; CONJUNCTIVA; CONJUNCTIVITIS; CORNEA; CORNEAL TRANSPLANTATION; CORNEAL ULCER; CYCLOSPORINE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MIDDLE AGED; MOLECULAR MIMICRY; NEUTROPHILS; PHACOEMULSIFICATION; POSTOPERATIVE COMPLICATIONS; RECURRENCE; S100 PROTEINS; VISUAL ACUITY;

EID: 34147185850     PISSN: 01815512     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Parunovic A, Brkic S, Vuckovic S. Corneal perforation in Mooren's ulcer. Immunological and clinical follow-up. Graefe's Arch Clin Exp Ophthalmol, 1988;226:330-1.
2. Van der gaag R, Abdillah H, Stilma JS, Vetter JCM. Circulating antibodies against corneal epithelium and hookworm in patients with Mooren's ulcer from Sierra Leone. Br J Ophthalmol, 1983;67:623-8.
3. Gottsch JD, Li O, Ashraf F, O'Brien TP, Stark WJ, Liu SH. Cytokine-induced calgranulin C expression in kératocytes. Clin Immunol, 1999;91:34-40.
4. Ilg EC, Troxler H, Burgisser DM, Kuster T, Market M, Guignard F, et al. Amino acid sequence determination of human S100A12 (P6, calgranulin C, CGRP, CAAF1) by tandem mass spectrometry. Biochem Biophys Res Commun, 1996;225:146-50.
5. Wilson SE, Lee WM, Murakami C, Weng J, Moninger GA. Mooren's corneal ulcers and hepatitis C virus infection. N Engl J Med, 1993;329:62.
6. Villar Arias MA, Vellila del campo E, Pinilla Moraza J, Anton Botella F. Mooren's corneal ulcers associated with Hepatitis C. Med Clin, 1998;110:719.
7. Majekodumni AA. Ecology of Mooren's ulcer in Nigeria. Doc ophtalmol, 1980;49:211-9.
8. Salamon SM, Mondino BJ, Zaidman GW. Peripheral corneal ulcers, conjunctival ulcers and scleritis after cataract surgery. Am J Ophthalmol, 1982;93:334-7.
9. David T, Morel X, Bigorgne C, Hoang-Xuan T, Renard G. Ulcère de Mooren après chirurgie combinée extraction Extracapsulaire du cristallin et trabéculectomie. J Fr Ophtalmol, 1997;20:619-23.
10. Mondinà BJ, Hofbauer JD, Foos RY. Mooren's ulcer after penetrating keratoplasty. Am J Ophthalmol, 1987;103:53-6.
11. Li R, Zhang W. A study of the immunopathology of Mooren's ulcer. Zhonghua Yan Ke Za Zhi, 1996;32:21-4.
12. Wang Z, Chen J, Zheng H. Changes in local immune functions in Mooren's ulcer. Yan Ke Xue Bao, 1996;12:33-5.
13. Kalogeropoulos CD, Malamou-Mitsi VD, Apsiotis MB, Psilas KG. Bilateral Mooren's ulcer in 6 patients: diagnosis, surgery and Histopathology. Int Ophthalmol, 2004;25:1-8.
14. Brown SI. Mooren's ulcer hisyopathology and proteolytic enzymes of adjacent conjunctiva. Br J Ophthalmol, 1975;59:670-4.
15. Watson PG. Management of Mooren's ulceration. Eye, 1997;11(Pt 3):349-56.
16. Taylor CJ, Smith SI, Morgan CH, Stephenson SF, Key T, Srinivasan M, Cunningham E Jr, et al. HLA and Mooren's Ulceration. Br J ophtalmol, 2000;84:72-5.
17. Chow CY, Foster CS. Mooren's ulcer. Int Ophthalmol Clin, 1996;36:1-13.
18. Jager MJ, Volker-Dieben HJ, De Waal L, Kok FG, Broersma L, Van der Gaag R. Genetic and clinical determinants for the T cell mediated immune response against the cornea specific protein BCP 54. Br J Ophthalmol, 1994;78:298-301.
19. Brown SI, Mondino BJ. Therapy of Mooren's ulcer. Am J Ophthalmol, 1984;98:1-6.
20. Agrawal V, Kumar A, Sangwan V, Rao GN. Indian J Ophthalmol, 1996;44:23-7.
21. Assouline M, Feumi C. Conduite à tenir devant un ulcère de Mooren. Réflexions Ophtalmologiques, 2002;7:55.
22. Wilson SE, Lee WM, Murakami C, Weng J, Moninger GA. Mooren-type hepatitis C virus-associated corneal ulceration. Ophthalmology, 1994;101:736-45.
23. Robert PY, Leconte V, Olive C, Ratsimbazafy V, Javerliat M, Adenis JP. Cyclosporin A eyedrops: manufacturing, toxicity, pharmacokinetics and indication in 2000. J Fr Ophtalmol, 2001;24:527-35.
24. Zhao JC, Jin XY. Treatement of severe Mooren's ulcer with cyclosporin A eyedrops. Chin Med J (Engl), 1992;105:406-9.
25. Tiev KP, Borderie V, Briant M, Ziani M, Morvant C, Baret M, et al. Severe Mooren's ulcer: efficacy of monthly cyclophosphamide intravenous pulse treatment. Rev Med Interne, 2003;24: 118-22.
26. Sangwan VS, Surender P, Burman S. Cataract surgery in patients with Mooren's ulcer. J Cataract Refract Surg, 2005;31:359-62.
27. Watanabe H, Katakami C, Tsukahara Y, Negi A. Cataract surgery in patients with advanced Mooren's ulcer. Jpn J Ophthalmol, 2001;45:543-6.
28. Akova YA, Aslan BS, Duman S. Phacoemulsification and intraocular lens implantation in a patient with mooren's ulcer. Ophthalmic Surg Lasers, 1997;28:769-71.